openPR Logo
Press release

Respiratory Syncytial Virus Market Growth, Trends & Forecast 2025 | Top key players - Sanofi, GSK plc, Pfizer.

05-27-2025 07:29 AM CET | Health & Medicine

Press release from: DataM Intelligence 4Market Research

Respiratory Syncytial Virus Market

Respiratory Syncytial Virus Market

The Global Respiratory Syncytial Virus (RSV) market reached USD 1.2 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 2.4 billion by 2030. The market is expected to exhibit a CAGR of 10.2% during the forecast period (2024-2031).

The Respiratory Syncytial Virus Market, as examined in the DataM Intelligence study, offers a comprehensive overview of the industry, enriched with in-depth insights, historical data, and key statistics. The report provides a thorough analysis of market dynamics, competitive strategies, and leading players, detailing their product offerings, pricing models, financial performance, expansion strategies, and regional presence.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID) @ https://datamintelligence.com/download-sample/respiratory-syncytial-virus-market?sz

The Respiratory Syncytial Virus (RSV) Market encompasses the development, production, and sale of diagnostic tests, vaccines, and therapeutic treatments targeting RSV infections. RSV primarily affects infants, young children, and older adults, causing respiratory illnesses. The market is driven by rising RSV incidence, growing awareness, and advancements in vaccine and antiviral drug development to prevent and manage severe respiratory infections globally.

Key Development

On May 3, 2023, GSK plc announced that the U.S. Food and Drug Administration (FDA) approved Arexvy, the world's first respiratory syncytial virus (RSV) vaccine designed specifically for adults aged 60 and older. Arexvy helps prevent lower respiratory tract disease (LRTD) caused by RSV, a serious infection especially dangerous for older adults.

On November 4, 2022, the European Commission approved Beyfortus, a long-acting medication developed by Sanofi and AstraZeneca. Also known as nirsevimab, Beyfortus is authorized to prevent RSV infections in newborns, protecting them from this common and highly contagious respiratory illness.

Major Players Shaping the Respiratory Syncytial Virus Market:

The prominent players in Respiratory Syncytial Virus market research report are: Sanofi, GSK plc, Pfizer, AstraZeneca, AbbVie, Bausch Health Companies, Bavarian Nordic, Merck & Co, Moderna, Inc., and mAbxience, among others.

The companies are primarily focusing on strategies such as new product launches to penetrate the fastest-growing emerging markets across the world.

Speak to Our Senior Analyst and Get Customization in the report as per your requirements @ https://datamintelligence.com/customize/respiratory-syncytial-virus-market

Market Segments

By Drug Type: Ribavirin, Nirsevimab, Virazole, Palivizumab, Riba Tab, Others.

By Dosage Form: Oral, Injectable, Inhaler, Others.

By Treatment Type: Immune prophylaxis, Supportive care, Antiviral Medications.

By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy.

The Respiratory Syncytial Virus industry is experiencing rapid growth, driven by advancements in medical technologies, increased demand for innovative therapies, and a rising focus on patient-centered care. As these sectors evolve, the need for comprehensive market analysis becomes crucial to understand trends, regulatory changes, and emerging opportunities.

Regions Covered:

The global Respiratory Syncytial Virus Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

☞ North America - US, Canada, Mexico

☞ Europe- Germany, Russia, UK, France, Italy, Rest of Europe

☞ Asia Pacific- China, India, Japan, Australia, Rest of Asia Pacific

☞ South America- Brazil, Argentina, Colombia, Rest of South America

☞ Middle East and Africa- Saudi Arabia, UAE, Oman, Bahrain, Qatar, Kuwait, Israel

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Respiratory Syncytial Virus Market Growth, Trends & Forecast 2025 | Top key players - Sanofi, GSK plc, Pfizer. here

News-ID: 4037265 • Views:

More Releases from DataM Intelligence 4Market Research

Oral Mucositis Market Poised for Strong Growth Driven by Rising Cancer Therapies & Advanced Treatments 2025 | DataM Intelligence
Oral Mucositis Market Poised for Strong Growth Driven by Rising Cancer Therapies …
Market Size and Growth: The Oral Mucositis Market reached US$ 1.62 billion in 2023 and is expected to reach US$ 2.30 billion by 2031, growing at a CAGR of 4.5% during the forecast period 2024-2031. Oral Mucositis Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay
Global Medical Second Opinion Market Soars as Patients Seek Accurate Diagnoses & Personalized Care 2025 | DataM Intelligence
Global Medical Second Opinion Market Soars as Patients Seek Accurate Diagnoses & …
Market Size and Growth: The Global Medical Second Opinion Market size reached USD 4,344.8 million in 2022 and is projected to witness lucrative growth by reaching up to USD 12,701.8 million by 2031. The medical second opinion market is expected to exhibit a CAGR of 14.8% during the forecast period 2024-2031. Medical Second Opinion Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and
Global Cancer Molecular Diagnostics Market Set for Strong Growth with Breakthrough Innovations by 2031 | DataM Intelligence
Global Cancer Molecular Diagnostics Market Set for Strong Growth with Breakthrou …
Market Overview: The Global Cancer Molecular Diagnostics market is expected to grow at a CAGR of 6.30% during the forecast period 2024-2031. Cancer Molecular Diagnostics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research
Global Gout Therapeutics Market Set for Strong Growth Driven by Rising Prevalence & Innovative Treatments 2025 | DataM Intelligence
Global Gout Therapeutics Market Set for Strong Growth Driven by Rising Prevalenc …
Market Size and Growth: The Gout Therapeutics Market size was valued USD 1.9 billion in 2021 and is estimated to reach USD 4.1 billion by 2031, growing at a CAGR of 8.2% during the forecast period (2024-2031). Gout Therapeutics Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions

All 5 Releases


More Releases for Respiratory

Prevalence Of Respiratory Diseases Fuels Demand For Respiratory Disposables: Key …
The Respiratory Disposables Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Respiratory Disposables Market Size During the Forecast Period? The respiratory disposables market has seen rapid growth in recent years. It is expected to grow from $1.01 billion in 2024 to $1.15
Transforming the Respiratory Monitoring Devices Market in 2025: Rising Incidence …
What Is the Expected Size and Growth Rate of the Respiratory Monitoring Devices Market? The market size for respiratory monitoring devices has seen swift expansion in the recent past. The market's growth is projected to increase from $1.67 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. A combination of factors such as the prevalence of respiratory ailments, an aging demographic, technological innovations,
Transforming the Respiratory Monitoring Devices Market in 2025: Rising Incidence …
What Is the Expected Size and Growth Rate of the Respiratory Monitoring Devices Market? The market size for respiratory monitoring devices has seen swift expansion in the recent past. The market's growth is projected to increase from $1.67 billion in 2024 to $1.87 billion in 2025, with a compound annual growth rate (CAGR) of 11.8%. A combination of factors such as the prevalence of respiratory ailments, an aging demographic, technological innovations,
Molecular Respiratory Panels Market: Enhancing Accuracy and Speed in Respiratory …
Introduction The global molecular respiratory panels market is rapidly evolving, driven by the need for faster, more accurate diagnostics in respiratory diseases. With respiratory infections and diseases becoming increasingly prevalent worldwide, accurate detection and timely diagnosis are critical to improving patient outcomes. Molecular respiratory panels, which utilize advanced molecular techniques like PCR (Polymerase Chain Reaction) and other nucleic acid-based methods, enable the rapid identification of pathogens responsible for respiratory conditions. These
Tackling Respiratory Challenges: Lower Respiratory Tract Therapeutics Market 202 …
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033. Lower Respiratory Tract Therapeutics Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance. The Market Size Is Expected To Reach $48.37 billion In
Respiratory Assist Devices Market - Breathing Uninterrupted: Innovating Respirat …
Newark, New Castle, USA - new report, titled Respiratory Assist Devices Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Respiratory Assist Devices market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Respiratory Assist Devices market. The report offers an overview of